Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

GOTTLIEB MICHAEL M. — Therapeutics Acquisition Corp. insider: 2 transactions · InsiderLens

Home / Insiders / GOTTLIEB MICHAEL M.

GOTTLIEB MICHAEL M.

Chief Commercial Officer at Therapeutics Acquisition Corp. · on record since Jun 30, 2021

Insider trading activity of GOTTLIEB MICHAEL M.

Transactions on record: 2; since Jun 30, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 8, 2021

Figures computed from official regulatory filings — methodology.

Companies where GOTTLIEB MICHAEL M. has traded

Therapeutics Acquisition Corp.2 tx · Jul 8, 2021

Track record of GOTTLIEB MICHAEL M.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of GOTTLIEB MICHAEL M.

Co-insiders of GOTTLIEB MICHAEL M.

BIOTECHNOLOGY VALUE FUND II LPTherapeutics Acquisition Corp.
BIOTECHNOLOGY VALUE FUND L PTherapeutics Acquisition Corp.
Biotechnology Value Trading Fund OS LPTherapeutics Acquisition Corp.
BVF GP HOLDINGS LLCTherapeutics Acquisition Corp.
BVF I GP LLCTherapeutics Acquisition Corp.
BVF II GP LLCTherapeutics Acquisition Corp.
BVF INC/ILTherapeutics Acquisition Corp.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BVF PARTNERS L P/ILTherapeutics Acquisition Corp.

BVF Partners OS Ltd.Therapeutics Acquisition Corp.

DEMERS WILLIAM L.Therapeutics Acquisition Corp.

FLESHNER NEIL E.Therapeutics Acquisition Corp.

GILMOUR MARGARET E.Therapeutics Acquisition Corp.

GOODMAN JONATHAN R.Therapeutics Acquisition Corp.

Grau DanielTherapeutics Acquisition Corp.

GRAY MICHAELTherapeutics Acquisition Corp.

Hammond MatthewTherapeutics Acquisition Corp.

HOGUE GERALD L.Therapeutics Acquisition Corp.

JENSEN JESSICA D.Therapeutics Acquisition Corp.

KELLY JUSTYNATherapeutics Acquisition Corp.

Kolchinsky PeterTherapeutics Acquisition Corp.

LAMPERT MARK NTherapeutics Acquisition Corp.

Lubner David CharlesTherapeutics Acquisition Corp.

Malik RajeshTherapeutics Acquisition Corp.

MARGOLIN YAELTherapeutics Acquisition Corp.

Martell Bridget ATherapeutics Acquisition Corp.

MCCANN JOE A.Therapeutics Acquisition Corp.

RA Capital Biotech Fund LPTherapeutics Acquisition Corp.

RA CAPITAL MANAGEMENT, LLCTherapeutics Acquisition Corp.

Shah Rajeev M.Therapeutics Acquisition Corp.

SILBER ALLAN CTherapeutics Acquisition Corp.

Therapeutics Acquisition Holdings LLCTherapeutics Acquisition Corp.

Company	Filed	Type	Qty	Price	Value · USD	Src
Therapeutics Acquisition Corp.	Jul 8, 2021	AwardD	48,000	0.00 USD	$0	SEC
Therapeutics Acquisition Corp.	Jun 30, 2021	Award	1,156,887	—	—	SEC